Form 8-K · Current Report · Filed 2025-05-22
Kenvue Inc. Completes $750 Million Senior Notes Offering
On May 22, 2025, Kenvue Inc. finalized the issuance of $750 million aggregate principal amount of 4.850% Senior Notes due 2032. The Notes were issued under an indenture between Kenvue and Deutsche Bank Trust Company Americas as trustee, with the proceeds intended for general corporate purposes. The Notes bear interest at a rate of 4.850% per annum, payable semi-annually, and mature on May 22, 2032. The offering includes provisions limiting certain corporate actions by Kenvue and its subsidiaries. A copy of the Second Supplemental Indenture is attached as Exhibit 4.1.
- Filer
- Kenvue Inc. KVUE · NYSE
- Filed
- Accession
- 0001628280-25-027285
- CIK
- 0001944048
- Signal
- Medium impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Entry into a Material Definitive Agreement
Creation of a Direct Financial Obligation
Financial Statements and Exhibits
Market reaction
Close before filing
$24.00
Next session
-1.1%
Since filing
-19.8%
Latest close
$19.24
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from KVUE reporting the same item, with the next session's move:
Exhibits (2)
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Never miss another KVUE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.